Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs. The newly […]

Duos Technologies to Present at the Microcap Conference 2025

Presentation Scheduled for Wednesday, January 29th at 10:30 AM ET JACKSONVILLE, FL / ACCESS Newswire / January 21, 2025 / Duos Technologies Group, Inc. ("Duos" or the "Company") (Nasdaq:DUOT), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30,

The Now Corporation (OTC: NWPN) Sees Opportunities for Community Solar Projects in California

PASADENA, CA / ACCESS Newswire / January 21, 2025 / The Now Corporation (OTC PINK:NWPN), an emerging leader in solar energy and utility solutions, announces its strategic focus on expanding into the California community solar market. This opportunity arises as California introduces new legislation, Assembly Bill 2316, designed to incentivize community solar projects that integrate

Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)

The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis – If successful, the Companies may explore clinical development in additional indications – Xyngari™ with Daxxify® has the potential to be the first approved needle-free intradermal delivery of a botulinum toxin product – SAN DIEGO,

Acclaimed Spanish Pianist Isabel Dobarro Releases First Solo Album: Kaleidoscope

Album is Dedicated to the Great Women Composers of our Time Artist and Activist has performed in the United States (Carnegie Hall), Spain, Germany, France, Russia, Belgium, Argentina, Italy, and Portugal NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Isabel Dobarro (www.isabeldobarro.com), one of the most internationally promising Spanish pianists of

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

— Company received written notice from the Nasdaq Listing Qualifications Staff stating that the Company regained compliance with the applicable Nasdaq minimum market value of listed securities continued listing requirement — Nasdaq stated that the matter is now closed NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (“NRx”, the “Company”), a clinical-stage biopharmaceutical company, today announced that on

Console Connect Collaborates with Connectbase to Enhance NaaS Capabilities

Console Connect, PCCW Global's on-demand platform and automated network for intelligent data movement, announced today its collaboration withConnectbase, the global ecosystem for buying and selling connectivity. This strategic initiative expands Console Connect's presence across the global connectivity marketplace as a leading network-as-a-service (NaaS) provider while enhancing Connectbase's capabilities in providing high-performance networking solutions. It brings

V-Technologies, the Developers of StarShip Announce Silver Sponsorship at Acumatica Summit 2025

Leading Provider of AcumaticaShipping Software,StarShip to Showcase Integrated Shipping Software at Acumatica Summit 2025 inLas Vegas, NVfromJanuary 26 to January 29, 2025. Join StarShip,shippingsoftwareprovider, V-Technologies, a leading provider of integrated shipping software for Acumatica, is proud to announce its Silver Sponsorship at the Acumatica Summit 2025, taking place in Las Vegas, NV from January 26

Wingstop Inc. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Wingstop Inc. (NASDAQ: WING) today announced that it will host a conference call and webcast to discuss its fiscal fourth quarter and full year 2024 financial results on Wednesday, February 19, 2025 at 10:00 a.m. ET. https://mma.prnewswire.com/media/1199181/Wingstop_Logo.jpg A press release with fiscal fourth quarter and full year 2024 financial results will be issued before the

Scroll to Top